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ABSTRACT
Background: Postbariatric surgery poly-neuropathies
(BSP) are infrequent events. However, with the number of
gastric bypasses performed each year increasing, the in-
cidence of BSP is expected to increase as well. The long-
term sequelae of BSP worsen with delays in diagnoses.
Therefore, early evaluation, recognition, and treatment
are important in minimizing morbidity and mortality.
Methods: We present the case report of a patient who
developed a poly-neuropathy after a laparoscopic
Roux-en-Y gastric bypass.
Results: The patient’s symptoms were ultimately deter-
mined to result from Guillain-Barre ´ syndrome. Symptoms
resolved with proper treatment.
Conclusion: Characteristic differences exist between the
various surgery poly-neuropathies. With proper evalua-
tion, this determination will aid in prompt and appropriate
treatment and will prevent morbidity and mortality.
Key Words: Bariatric surgery poly-neuropathy, Guillain-
Barre ´ syndrome, laparoscopic Roux-en-Y gastric bypass.
INTRODUCTION
Poly-neuropathies are an uncommon condition and may
result from several causes. These include drugs, metabolic
disorders, environmental exposure, vitamin deficiencies,
conversion disorders, and inflammation. Drug-related
neuropathies, ie, exposure to cisplatin, chloramphenicol,
dapsone, isoniazid, metronidazole, nitrofurantoin, pyri-
doxine, amiodarone, tetanus toxoid, and diphtheria toxin,
are the most common type.1 Metabolic disorders that can
cause poly-neuropathies include diabetes mellitus, ure-
mia, hypothyroidism, hepatic failure, polycythemia, and
porphyria.2 Environmental exposure, such as to toxins
(acrylamide, carbon disulfide, ethylene oxide, and carbon
monoxide), metals (mercury, gold, and thallium), and
alcohol can also result in a poly-neuropathy.3
Acquired deficiencies in thiamine (vitamin B1) and cyano-
cobalamin (vitamin B12) are the most common causes of
postbariatric surgery poly-neuropathies (BSP).4–8 Inflam-
matory causes of BSP include Guillian-Barre ´ syndrome
(GBS), myasthenia gravis, human immunodeficiency virus
associated poly-neuropathy, lupus erythematosus associ-
ated poly-neuropathy, and chronic active hepatitis asso-
ciated poly-neuropathy.9
The literature has revealed that the incidence of BSP is
0.06% (5.9 cases per 10 000 operations).4 Similarities be-
tween thiamine deficiency and GBS include the presence
of protracted vomiting, weakness, and hyporeflexia. The
long-term sequela of each disease varies, but worsens
with delays in diagnoses and treatment. Therefore, estab-
lishing the correct diagnoses early will minimize morbidity
and mortality.
CASE REPORT
A 40-year-old female with a body mass index of 60, who
met the National Institutes of Health criteria for weight
loss surgery, underwent an uneventful antecolic antegas-
tric laparoscopic Roux-en-Y gastric bypass. Postopera-
tively, she experienced an episode of nausea and vomit-
ing that resolved spontaneously. She was discharged
home on postoperative day 2.
Subsequently, the patient was readmitted 3 times in 5
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CASE REPORTmonths for protracted nausea, vomiting, lethargy, and
weakness. On her first admission, her physical examina-
tion and electrolytes were normal. An upper gastrointes-
tinal study with small-bowel follow-through and an
esophagogastroduodenoscopy were negative for small-
bowel obstruction, anastomotic stricture, and marginal
ulcer. At her second admission, on postoperative week 8,
she was managed conservatively with intravenous fluids
and electrolyte replacement. She was readmitted 4 weeks
later with an exacerbation of her nausea, vomiting, and
right upper quadrant tenderness. A CT scan of the abdo-
men obtained during this admission revealed cholelithia-
sis. Although her preoperative ultrasound had been neg-
ative, symptomatic cholelithiasis was considered as a
possible cause of her symptoms. She, therefore, under-
went an uneventful laparoscopic cholecystectomy. After
her surgery, she was noted to have inadequate oral intake
and persistent nausea and vomiting; therefore, a PICC line
was placed for home TPN with vitamin and nutritional
supplements. Prior to discharge, the patient noted the
onset of mild numbness and tingling extending from her
lower extremities to her abdomen. She was discharged
home on postoperative day 2.
At home, her symptoms rapidly progressed within 1 week
from bilateral lower extremity cramping and burning to an
inability to walk or stand. The patient underwent a neu-
rologic workup. A head CT, MRI, cerebral spinal fluid
smear and culture were negative. She was referred to a
neurologist at a rehabilitation facility for further evalua-
tion.
The neurologist’s evaluation showed bilateral 3/5 motor
strength in her distal lower extremities, markedly de-
creased sensation from the middle of her thigh distally,
decreased vibration sense in her lower extremities, and
absent ankle and knee-jerk reflexes. Laboratory studies
included a normal CBC and electrolytes, serum alkaline
phosphatase of 164 (normal, 25 to 150), serum AST of 274
(normal, 0 to 40), serum ALT of 145 (normal, 0 to 40),
glycosylated hemoglobin of 4.3 (normal, 4.5 to 5.7), neg-
ative Lyme titer, Vitamin B12 level of 691 (normal, 211 to
911), folic acid level of 9.7 (normal 5.4) and serum
albumin of 3.5 g/dL.
Nerve conduction studies (NCV) revealed florid fibrilla-
tions and positive waves in the gastrocnemius, peroneous
longus, and adductor longus muscles indicating a signifi-
cant sensorimotor distal polyneuropathy. These findings
were consistent with the axonal form of GBS. The patient
was prescribed Gabapentin 100 mg at night, and contin-
ued her rehabilitation with physical therapy. Her symp-
toms gradually improved; however, she required the as-
sistance of a walker for 6 months before her symptoms
completely resolved.
DISCUSSION
GBS is an acute postinfectious autoimmune syndrome
affecting the peripheral nerves and resulting in ascending
symmetrical motor and sensory deficits. Classic symptoms
on presentation, after bariatric surgery, include protracted
nausea, vomiting, and lower extremity weakness.4,5 Gen-
eralized weakness can progress over days to weeks. GBS
can also present with cranial nerve deficits and respiratory
compromise. The patient may describe a viral or bacterial
infection 1 week to 3 weeks prior to symptoms.
Infection with Campylobacter jejuni specifically has been
linked to the initiation of symptoms.10 Other associated
infections include Epstein-Barr virus, varicella-zoster vi-
rus, human immunodeficiency syndrome, and Myco-
plasma pneumoniae.11–13 The diagnosis is made based on
history, physical examination, electromyography, nerve
conduction studies, and cerebral spinal fluid test results.
Our patient underwent an extensive evaluation by a neu-
rologist. The findings were consistent with GBS. Paulson
et al14 found that 4 of 6 patients in his study, in addition to
nutritional deficiencies, were found to have GBS by elec-
tromyography (EMG). Symptoms included confusion, in-
appropriate behavior, profound weakness, and paraple-
gia. Feit et al15 reported on 2 patients with postgastric
partitioning poly-neuropathy. Both patients had symp-
toms of hysteria, protracted nausea and vomiting, and
severe paraplegia. Diagnostic workups, including a neg-
ative cerebral spinal fluid aspirate, were inconclusive for
both patients. However, both patients had an EMG that
documented a demyelinating poly-neuropathy. Chang et
al4 reported on 2 patients who underwent open gastric
bypass and were postoperatively diagnosed with GBS.
One patient had an inconclusive finding on EMG, but was
assigned a diagnosis of GBS. Treatment was initiated with
plasmapheresis followed by intravenous immunoglobulin
(IVIG). Once started on antipsychotics (for her dysesthe-
sias), this patient developed psychosis. The medication
was discontinued and the psychosis resolved.
The second patient had typical GBS findings on EMG and
NCV studies. She was treated with IVIG, which resulted in
marked improvement. Sassaris et al16 identified 3 of 4
patients, and Abarbanel et al17 identified 4 of 20 patients
who had post-BSP treated with vitamin supplementation.
Over 50% of their patients had an unknown cause of their
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spite vitamin supplementation. Teitleman et al18 report on
a patient treated with thiamine with resolution of symp-
toms. Machado et al19 report similar findings in a postbari-
atric surgery patient with resolution after treatment with
immunoglobulin and vitamin supplementation.
GBS has many variants distinguished by physical symp-
toms and syndrome progression. Several diagnostic stud-
ies are used to evaluate GBS. These studies, guided by the
patient’s history and presentation, include a cerebral spi-
nal fluid (CSF) aspiration to assess elevated protein (0.55
g/L), a thyroid panel, rheumatology profiles, vitamin B1,
vitamin B12, folic acid, glycosylated hemoglobin, erythro-
cyte sedimentation rate, rapid plasmin reagin, immuno-
electrophoresis of serum protein, a heavy metal test, and
serum auto antibodies against glycolipids on the surface
of C. jejuni.
10 Electromyography in GBS shows abnormal-
ities consistent with demyelination.
Treatment options include physical therapy, occupational
therapy, and speech therapy. ICU monitoring for respira-
tory failure and deep venous thrombosis (DVT) prophy-
laxis for prolonged immobility are also indicated. Spe-
cialty consults may include neurology, critical care,
pulmonology, and surgery. Medical therapy may include
IVIG, plasma exchange, nonsteroidal anti-inflammatory
drugs, opioids, and Gabapentin.17 Van der Meche et al20
showed that IVIG is indicated in patients with sensory
variant GBS with prolonged, unresolved symptoms, but
plasmapheresis has been shown to be equally effective in
treating GBS. Immobility will require deep venous throm-
bosis prophylaxis, rehabilitation, and frequent turning to
prevent decubitus ulcers. As an outpatient, the patient
should be followed as needed by neurology, physical
therapy, occupational therapy, and speech therapy.
Seventy-five percent to 85% of patients will have complete
recovery.21,22 Fifteen percent to 20% will have residual
motor and sensory deficits, and 1% to 10% will be severely
disabled.21,22 Two percent to 12% of patients will die from
complications (eg, ventilator-associated pulmonary infec-
tion) associated with GBS.22 Recovery is dependent on
many factors including timeliness of diagnosis, acuity of
the onset of symptoms, age of patient, concurrent infec-
tions, and need for ventilator support.21,22
The differential diagnosis of BSP can be challenging. GBS
and its variants23 can be confused with thiamine defi-
ciency with manifestations of dry beriberi and Wernicke’s
encephalopathy. Both present with lower extremity weak-
ness, ataxia, and ophthalmoplegia. Differentiating factors
include history and the results of EMG, NCV, and CSF.
CONCLUSION
BSP is a complication that may increase in incidence as
the number of bariatric surgery procedures increase. Un-
derstanding its clinical presentation, differential diag-
noses, proper evaluations, and treatment are necessary to
minimize morbidity and mortality. It is prudent to evaluate
for nutritional deficiencies (vitamin levels, prealbumin,
transferrin, retinol binding protein), provide vitamin B1
and B12 supplementation, and treat according to findings
obtained during a comprehensive neurological and psy-
chological examination. A high index of suspicion and
early recognition are essential in preventing morbidity and
mortality.
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